Hansen Gwenn Insider Trading Activity
Hansen Gwenn has been net-selling over the last 12 months with 0 purchases and 8 sales across 1 company.
NRIX is the most-traded position with 8 trades. The largest single transaction was a sale of NRIX for $109K on Aug 5, 2026.
Performance Scorecard
Forward stock performance after each transaction by Hansen Gwenn. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | -2.7% | 33% | 9 |
| 90 days | — | -15.5% | 40% | 5 |
| 120 days | — | -26.9% | 0% | 5 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersNRIX · Nurix Therapeutics, Inc.
🔒 Subscribe to see trade entries
Pro members see exactly when Hansen Gwenn bought and sold NRIX.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
Aug 5, 2026 | NRIX | Sell | 4,356 | $25.00 | $109K | −3.6% | Chief Scientific Officer | |
Aug 4, 2026 | NRIX | Sell | 2,611 | $24.64 | $64K | −2.2% | Chief Scientific Officer | |
Aug 4, 2026 | NRIX | Sell | 1,500 | $23.87 | $36K | −1.2% | Chief Scientific Officer | |
Jul 30, 2026 | NRIX | Sell | 3,847 | $23.38 | $90K | −3.1% | Chief Scientific Officer | |
Apr 30, 2026 | NRIX | Sell | 3,214 | $16.65 | $53K | −2.6% | Chief Scientific Officer | |
Jan 30, 2026 | NRIX | Sell | 98 | $17.37 | $2K | −0.1% | Chief Scientific Officer | |
Jan 30, 2026 | NRIX | Sell | 4,797 | $16.58 | $80K | −5.4% | Chief Scientific Officer | |
Oct 30, 2025 | NRIX | Sell | 4,087 | $12.80 | $52K | −5.1% | Chief Scientific Officer | |
Jul 30, 2025 | NRIX | Sell | 4,308 | $12.01 | $52K | −5.9% | Chief Scientific Officer |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| NRIX | Nurix Therapeutics, Inc. | 9 | $538K |
Other insiders at Nurix Therapeutics, Inc.
2 other tracked filers at NRIX.